Together we will find a cure Donate
Together we will find a cure Donate

News

National brain tumour research funding needs to increase to £35 million a year

‘Paying the price of cancer’ – new research published

New research has uncovered that for many, the long-term financial impact of cancer can reach more than a year’s average UK salary.

Analysis from Macmillan Cancer Support, reported in today’s Independent newspaper, reveals that more than four in five people living with cancer – almost 2.5 million people across the UK – are hit by a ‘cancer price tag’ that reaches almost £900 a month. Further research also shows there are still tens of thousands of people with cancer in the UK struggling to pay basic living costs because of the COVID-19 pandemic.

The financial hit that many people face as a result of a cancer diagnosis can come from an array of extra and often unexpected needs, as well as a drop in earnings if they are less able to work. For example, the latest figures show that more than half of people with cancer see an increase in day-to-day living costs (54%), with more than a quarter experiencing extra costs travelling to and from their appointments (28%), and around one in six (17%) facing higher household fuel bills. In addition, three in four people with cancer (75%) experience a loss of income.

In 2018, Brain Tumour Research published its ‘Exposing the financial impact of a brain tumour’ report which revealed that the financial impact of a brain tumour diagnosis is more than double that of other cancers.

The report outlined that an average household will lose £14,783 per year following a brain tumour diagnosis versus £6,840 for all cancers. Other key findings included that those affected pay nearly an extra £1,000 per year on household bills, with 30% of survey respondents having to make costly home modifications as a result of their diagnosis; patients are required to surrender their driving licence, leading to a loss of independence and ability to work; and brain tumour patients often fall into debt, owing an average of £4,762.

These findings were submitted to the All-Party Parliamentary Group on Brain Tumours (APPGBT) first ever Inquiry, which resulted in the publication of its 'Brain Tumours - a cost too much to bear?’ report.

Read more about this new research in The Independent here.

Related reading:

If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.

Donate today

Help us build the UK's largest network of experts in sustainable brain tumour research and campaign for more investment nationally. Together we will find a cure.

£10
£25
£50
£100